AirSculpt Technologies vs biote
biote reported revenue of $192 million in fiscal 2025, 1.3 times AirSculpt Technologies' $152 million in fiscal 2025. AirSculpt Technologies' revenue fell 15.8% in its latest year, and biote's fell 2.5%. AirSculpt Technologies had an operating margin of -7.6%, against 18.5% at biote. Free cash flow was $1 million at AirSculpt Technologies and $30 million at biote.
Side by side
| AirSculpt Technologies | biote | |
|---|---|---|
| Latest fiscal year | FY2025, Dec 31, 2025 | FY2025, Dec 31, 2025 |
| Revenue | $152M | $192M |
| Revenue growth | −15.8% | −2.5% |
| Revenue growth a year, last 5 years | 19.3% | — |
| Gross margin | — | — |
| Operating margin | −7.6% | 18.5% |
| Net margin | −7.7% | 14.1% |
| Free cash flow | $1M | $30M |
| Free cash flow margin | 0.5% | 15.7% |
| Return on capital | −6.6% | — |
| Net debt to EBITDA | 39.0x | 2.0x |
| Dividends and buybacks | $0M | $5M |
| Change in diluted share count | 4.8% | 7.0% |
| Last close | $0.65 | $0.84 |
| P/E at the last close | — | — |
| Insider trades, last 12 months | bought $2.0 million, sold $0 | bought $202,204, sold $0 |
| Piotroski F-score | 3 of 8 | 5 of 8 |
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.
Ten years
Revenue
US$ billions, fiscal years
AirSculpt Technologiesbiote
Operating margin
Percent of revenue
AirSculpt Technologiesbiote
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
AirSculpt Technologiesbiote
Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the AirSculpt Technologies and biote pages.